Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;49:328-333
Published online before print December 11, 2006, doi: 10.1161/01.HYP.0000253478.51950.27
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
49/2/328    most recent
01.HYP.0000253478.51950.27v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hagedorn, K. A.
Right arrow Articles by Davidge, S. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hagedorn, K. A.
Right arrow Articles by Davidge, S. T.
Related Collections
Right arrow Other Vascular biology

(Hypertension. 2007;49:328.)
© 2007 American Heart Association, Inc.


Original Articles

Regulation of Vascular Tone During Pregnancy

A Novel Role for the Pregnane X Receptor

Kathryn A. Hagedorn; Christy-Lynn Cooke; John R. Falck; Bryan F. Mitchell; Sandra T. Davidge

From the Perinatal Research Centre (K.A.H., C.-L.C., B.F.M., S.T.D.), Departments of Obstetrics/Gynecology and Physiology, University of Alberta, Edmonton, Alberta, Canada; and the Department of Biochemistry (J.R.F.), University of Texas Southwestern Medical Center, Dallas.

Correspondence to Sandra T. Davidge, Perinatal Research Centre, 232 HMRC, Departments of Obstetrics/Gynecology and Physiology, University of Alberta, Edmonton, Alberta, Canada T6G 2S2. E-mail sandra.davidge{at}ualberta.ca

During pregnancy, maternal vascular function is altered through mechanisms that remain unclear. Progesterone synthesis and metabolism are also increased. Progesterone metabolites are potent endogenous ligands for the pregnane X receptor (PXR), a nuclear receptor that induces the expression of hepatic cytochrome P450 enzymes. Cytochrome P450 enzymes located in the vasculature can metabolize arachidonic acid to produce epoxyeicosatrienoic acids, known vasodilators. We hypothesized that PXR is present in vascular tissue and contributes to vascular adaptations to pregnancy. PXR mRNA was detected in mouse mesenteric arteries by quantitative RT-PCR. Constrictor and relaxation responses in wildtype (PXR+/+) and PXR-deficient (PXR–/–) mice were compared by wire myography. Relative to nonpregnant controls, arteries from pregnant PXR+/+ mice had reduced sensitivity to phenylephrine-induced constriction (EC50: 2.77±0.32 µmol/L versus 5.13±0.36 µmol/L; P=0.009) and enhanced maximal vasorelaxation to bradykinin (26±3% versus 44±16%; P=0.013). However, these pregnancy adaptations were absent in PXR–/– mice. We also hypothesized that PXR is activated by progesterone metabolites. Treatment of PXR+/+ and PXR–/– nonpregnant mice with 5ß-dihydroprogesterone for 7 days enhanced endothelium-dependent relaxation in only the PXR+/+ mice, similarly to that seen in pregnancy. In treated mice, inhibition of cytochrome P450 epoxygenase activity with N-methylsulphonyl-6-(2-propargyloxyphenyl)hexanamide attenuated vasorelaxation in arteries from PXR+/+ but not PXR–/– mice. We conclude that PXR contributes to the development of vascular adaptations to pregnancy, likely in response to activation by progesterone metabolites, and that PXR-dependent increases in vasorelaxation may be because of activation of cytochrome P450 epoxygenases.


Key Words: pregnancy • vascular tone • pregnane X receptor • cytochrome P450




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
S. R. Pondugula, C. Brimer-Cline, J. Wu, E. G. Schuetz, R. K. Tyagi, and T. Chen
A Phosphomimetic Mutation at Threonine-57 Abolishes Transactivation Activity and Alters Nuclear Localization Pattern of Human Pregnane X Receptor
Drug Metab. Dispos., April 1, 2009; 37(4): 719 - 730.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
B. Gellersen, M.S. Fernandes, and J.J. Brosens
Non-genomic progesterone actions in female reproduction
Hum. Reprod. Update, January 1, 2009; 15(1): 119 - 138.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. D. LaMarca, J. Gilbert, and J. P. Granger
Recent Progress Toward the Understanding of the Pathophysiology of Hypertension During Preeclampsia
Hypertension, April 1, 2008; 51(4): 982 - 988.
[Full Text] [PDF]